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http://dx.doi.org/10.1016/j.jfma.201Background/Purpose: Medical systems and care for diabetes have changed greatly in Taiwan in
recent years. This study investigated mortality trends in patients with diabetes in Taiwan from
2000 to 2009.
Methods: We linked the National Health Insurance (NHI) claims database, which contains data
on 99% of the population of Taiwan, to the National Death Registry and Cancer Registry.
Patients were classified as having diabetes if they had at least one hospital admission or three
or more outpatient visits with a diabetes diagnostic code in each calendar year. Mortality data
from the Collaboration Center of Health Information Application were used to estimate age-
and sex-specific mortality rates, all-cause mortality, and life expectancy (LE).
Results: The mortality of patients with diabetes in Taiwan decreased continuously from 2000
to 2009 for both sexes and all age groups; the mortality rate was generally higher for men than
for women (3.92% vs. 3.29% in 2000; 3.64% vs. 3.11% in 2005, and 3.12% vs. 2.71% in 2009, all
p < 0.05). Diabetic patients had a shorter LE than the entire population, although this differ-
ence decreased over time. The estimated loss of life due to diabetes was 6.1 years in women
and 5.3 years in men in 2009, when diabetes was diagnosed at the age of 40. The four major
causes of death were diabetes, malignancies, heart diseases, and cerebrovascular diseases.
Conclusion: The mortality of diabetic patients in Taiwan decreased from 2000 to 2009.
Although patients with diabetes had a shorter LE than the entire population, the difference
decreased over time.
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646 H.-Y. Li et al.Introduction diagnosed as having DM on discharge (The InternationalDiabetes mellitus (DM) is now a pandemic, as a result of
population aging, lifestyle changes, and obesity. In 2011, an
estimated 366 million people had DM, and this number is
predicted to increase to 552 million in 2030.1 DM is often
associated with complications, such as retinopathy,
nephropathy, neuropathy, and cardiovascular diseases.2
Patients with DM have a higher mortality rate than those
without DM.3e6 Therefore, DM and its complications impose
a heavy burden on personal and public health globally.
From 1960 to 1988 there were big socioeconomic changes
in Taiwan, and these were accompanied by changes in die-
tary habits and lifestyle. Since then, DM has become a major
threat to health in Taiwan. During those earlier years, the
importance of treating DM and its complications was not well
known, and little attention was paid to DM. This conse-
quently resulted in increasing mortality from DM between
1960 and 1988.7 In 1995, a compulsory National Health
Insurance (NHI) program, which encompassed nearly all the
citizens, was implemented in Taiwan. As the NHI reduced
medical costs dramatically, more sick individuals sought
medical care. Consequently, there was a marked increase in
the number of patients with end-stage renal disease recor-
ded after the NHI implementation.8 In 1996, a share care
program for DM was established to improve quality of care.9
In 2001, this programwas imbursedbyNHI in awayof pay-for-
quality.
Over the last fewdecades,many newmethods have been
developed for treating DM and its complications: these
include new anti-diabetic drugs, insulin analogues,
improved stroke management, and new techniques for
coronary arterial diseases treatment. However, no study
has investigated whether these changes have made any
difference to the mortality rate of DM patients. We thus
studied mortality trends in patients with DM in Taiwan from
2000 to 2009. We estimated their life expectancy (LE) loss
due to DM and reported their major causes of death.
Materials and methods
Data source
A single-payer compulsory NHI program was implemented in
Taiwan in 1995. The Taiwan NHI claims database includes
data on complete outpatient visits, hospital admissions,
prescriptions, disease and vital status of 99% of the total
population of Taiwan, which is 23million.We established the
longitudinal medical history of each beneficiary by linking
several computerized administrative and claims datasets,
including the National Death Registry and Cancer Registry,
through both the civil identification number unique to each
beneficiary and their dateof birth. Theprotocol for this study
was approved by the Research Ethics Committee of the
Taiwan Center for Disease Control and the Institutional
Review Board of National Taiwan University Hospital.
Study population
We explored the Taiwan NHI database to identify patients
with any history of hospitalization and who had beenClassification of Diseases, ninth Revision, Clinical Modifi-
cation, ICD-9-CM code 250) from 2000 to 2009, and used
outpatient claims to find any visit for DM (ICD-9-CM code
250 and A code A181). Patients were classified as having DM
and were included in the study if they had at least one
hospital admission with a diagnostic code of DM or three or
more outpatient visits with a DM diagnostic code in each
calendar year. Mortality data obtained from the Collabo-
ration Center of Health Information Application were used
to estimate age- and sex-specific mortality rates, all-cause
mortality, and LE.
Statistical analysis
We calculated all-cause mortality for different age and sex
groups by year. Standardized mortality was calculated
according to the age- and sex-specific distribution of
Taiwanese people in 2005 and the standard population of
the World Health Organization (WHO) in 2000. The impact
of DM on LE was calculated using Greville’s method and the
mortality rates of DM patients. The LE of the entire pop-
ulation was also calculated using Greville’s method and the
mortality rates obtained from the Department of Statistics,
Ministry of the Interior (http://sowf.moi.gov.tw/stat/Life/
T05-lt-quary.html). The top four causes of death were re-
ported as a percentage of all deaths of patients with DM by
sex and by year. We performed the trend tests to examine
the linear gradient relationship about the risk of endpoints
of interest. The Chi-square tests were used to identify the
differences in mortality rates among the three age groups.
All statistical analyses were performed with the SAS version
9.1 (SAS Institute, Cary, NC). A p value of less than 0.05 was
set to declare statistical significance.
Results
Table 1 summarizes the characteristics of patients with DM
in Taiwan from 2000 to 2009. The population of diabetic
patients increased from 0.67 million in 2000 to 1.25 million
in 2009. The mean age was 61.35 years in 2000 and 62.40
years in 2009. Half of diabetic patients were 40e65 years
old, and 4.5e6.0% were younger than 40 years. The ratio of
women to men was about 1:1 with more women with DM in
2000e2003 and more men with DM in 2005e2009.
As shown in Table 2, women with DM had lower all-cause
mortality than men with diabetes in 2000e2009. In 2009,
the mortality rate was 2.71% in women and 3.12% in men.
There was a reducing trend in the mortality rate of both
sexes from 2000 to 2009 (all p < 0.005). The mortality rate
for women was 3.92% in 2000, 3.11% in 2005, and 2.71% in
2009, whereas for men it was 3.92% in 2000, 3.64% in 2005,
and 3.12% in 2009. Men aged 65 years of age had the
highest mortality rate followed by those aged between 40
and 65 years and those younger than 40 years. Similarly,
women aged 65 years had the highest mortality rate.
However, women younger than 40 years had a slightly
higher mortality rate than those aged 40e65 years in
2000e2007, although the difference in the mortality rate
was small. In each age group, the mortality rate was
reduced from 2000 to 2009 for both sexes.
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Mortality in patients with diabetes in Taiwan 647The standardized mortality rate was less than half the
crude mortality rate (Table 3), suggesting that the age
distribution of DM patients had a great impact on the all-
cause mortality. Indeed, the mean age of DM patients was
much older (61.86  12.86 years in 2000, 63.19  13.45
years in 2009) than that of the entire population
(33.53  20.33 years in 2000, 37.62  20.67 years in 2009).
Women had a lower standardized mortality rate than did
men. From 2000 to 2009, there was a reducing trend in
mortality, standardized to the age- and sex-specific distri-
bution of Taiwanese in 2005, with borderline statistical
significance (p Z 0.06). However, when mortality was
standardized to the WHO 2000 standard population, there
was no statistically significant trend in mortality (pZ 0.4).
DM patients had shorter LE than the entire population
(Table 4). In 2009, 6.1 years (women) or 5.3 years (men) of
LE was lost when DM developed at the age of 40. The LE was
longest when DM developed at 65 years old, and was
shortest when DM developed at birth. The difference in LE
between DM patients and the entire population was largest
when DM developed at birth and smallest when DM devel-
oped at the age of 65. In other words, when DM developed
later in life, the LE was longer, with fewer years of LE lost in
both sexes. Similar to the scenario for the entire pop-
ulation, women with DM had longer LE than men with DM,
no matter when DM developed. When DM developed at
birth, women lost fewer years’ LE than men. When DM was
diagnosed at the age of 40, loss in LE was similar in both
sexes. However, when DM developed at the age of 65,
women lost more years of LE than men. To sum up, when
DM developed at a younger age, men lost more years of LE
than women. However, when DM developed at an older age,
women lost more years of LE than men. From 2000 to 2009,
LE increased, and the number of years of LE lost decreased
in both sexes (all p < 0.05).
As shown in Table 5, the top four causes of death for DM
patients were DM, malignancies, heart diseases, and cere-
brovascular diseases. In 2000, the first, second, third and
fourth most frequent causes of death were DM, malignan-
cies, cerebrovascular diseases, and heart diseases,
respectively, for both sexes. From 2000 to 2009, there was
an increasing trend in the percentage of patients who died
from malignancies and heart diseases, and this was
accompanied by a reduction in the percentage of patients
who died from DM and cerebrovascular diseases for both
sexes (all p < 0.005). As a result of this, malignancies
replaced DM to become the leading cause of death in men
with DM in 2009. Heart diseases replaced cerebrovascular
diseases to become the third most frequent cause of death
in men and women with DM in 2009.Discussion
In the present study, we demonstrated that the mortality
rate of patients with DM continuously decreased between
2000 and 2009 in Taiwan for both sexes and all age groups.
As a result, the patients’ LE increased between 2000 and
2009. However, patients with DM still had a shorter LE than
the entire population, although the difference in LE
reduced over time. In 2009, the estimated reduction in LE
was 6.1 years for women and 5.3 years for men, when DM
Table 2 All-cause mortality in DM patients by sex and age group from 2000 to 2009.
Sex Age groups 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 p for trend
Female <40 years 1.46% 1.63% 1.48% 1.24% 1.51% 1.44% 1.26% 1.18% 1.06% 1.00% 0.002
40e65 years 1.26%a 1.25%a 1.13%a 1.08%a 1.11%a 1.17%a 1.10%a 1.05%a 0.98% 0.95% <0.001
65 years 5.58%a,b 5.60%a,b 5.49%a,b 5.26%a,b 5.44%a,b 5.29%a,b 4.86%a,b 4.91%a,b 4.72%a,b 4.59%a,b <0.001
Total 3.29% 3.32% 3.23% 3.11% 3.26% 3.11% 2.88% 2.90% 2.79% 2.71% <0.001
Male <40 years 2.06% 1.99% 1.82% 1.63% 1.71% 1.57% 1.49% 1.30% 1.20% 1.11% <0.001
40e65 years 2.11% 2.06% 1.94% 1.74% 1.86% 1.91%a 1.85%a 1.71%a 1.69%a 1.57%a 0.001
65 years 6.43%a,b 6.66%a,b 6.40%a,b 6.30%a,b 6.52%a,b 6.50%a,b 6.03%a,b 6.07%a,b 5.96%a,b 5.77%a,b 0.002
Total 3.92%c 3.97%c 3.77%c 3.60%c 3.75%c 3.64%c 3.42%c 3.35%c 3.28%c 3.12%c <0.001
a p < 0.05 vs. <40 years old in the corresponding sex.
b p < 0.05 vs. 40e65 years old in the corresponding sex.
c p < 0.05 vs. female.
648 H.-Y. Li et al.was diagnosed at the age of 40. The four major causes of
death in DM patients were DM, malignancies, heart
diseases, and cerebrovascular diseases.
From 1960 to 1988, mortality from DM increased 6.3-fold
in Taiwan based on the analyses of death certificates by Lin
et al.7 The results of the present study showed that the
mortality rate in DM patients declined continuously from
2000 to 2009 for both sexes and all age groups. One
important reason for the improvement in the mortality rate
of DM patients was the implementation of the NHI in 1995.
This insurance reduced the cost of medical services for DM
patients. As the insurance is compulsory and covers 99% of
Taiwanese, most DM patients received medical care for
both metabolic control and management of diabetic
complications. Indeed, the recorded incidence and preva-
lence of end-stage renal disease increased markedly in
1995, the year in which the NHI was implemented.8 The
gross domestic product in Taiwan has increased from $US
9016 in 1991 to $US 20,122 in 2011.10 As a result, more
money can be spent for medical care. In 1996, a share care
program for diabetes that defined the indices for the
quality of DM care was established.9 In 2001, the share care
program was imbursed by the NHI in a way of pay-for-
quality. Moreover, thetreatment for DM and its complica-
tions has also improved dramatically over the past 2
decades. For example, the use of percutaneous trans-
luminal coronary angioplasty and stents has greatly
improved the outcome for patients with cardiovascular
diseases,11 which were the major cause of death of DM
patients both in this study and in previous studies.1 MedicalTable 3 Crude and standardized mortality in DM patients from
2000 2001 2002 2003 200
Crude death rate 3.59% 3.62% 3.48% 3.34% 3.4
Female 3.29% 3.32% 3.23% 3.11% 3.2
Male 3.93% 3.97% 3.77% 3.60% 3.7
Standardized mortalitya 1.54% 1.53% 1.49% 1.27% 1.3
Female 1.23% 1.25% 1.19% 1.06% 1.0
Male 1.80% 1.76% 1.75% 1.44% 1.5
WHO 2000-Standardized
mortalityb
1.35% 1.38% 1.40% 1.10% 1.1
a Standardized according to the age- and sex-specific distribution o
b Standardized according to the standard population of the World Hcare for end-stage renal disease has also improved, espe-
cially since the NHI was implemented, and this has resulted
in a reduction in the mortality rate of patients with end-
stage renal disease.8 These are the probable reasons for
our findings and for the decrease in the difference in LE
between DM patients and the entire population from 2000
to 2009.
In the present study, the all-cause mortality in DM
patients was reduced by 17.6% in men (from 3.29% in 2000
to 2.71% in 2009) and by 20% in women (from 3.92% in 2000
to 3.12% in 2009) during the decade. Two previous studies
have investigated mortality trends in DM patients over
a similar time period.12,13 Among adults in the U.S., the all-
cause mortality rate of DM patients reduced by 23% from
1997 to 2004 in both sexes.12 In Ontario, Canada, the all-
cause mortality rate in DM patients decreased by 25%
from 1995 to 2005.13 Comparing recent and previous
mortality rates, Preis et al found that the all-cause and
cardiovascular mortality rates were lower in U.S. adults
with DM in 1986e2001 compared with those in 1950e1975.4
In the U.K., the mortality rate of DM patients aged 45
years was lower in 1990e1994 than in 1970e1974.6 These
data suggest that there has been a continuous decline in
mortality among DM patients over the past decades in
Western developed countries.
Several reports have shown that DM patients have
a higher mortality rate than patients without DM.3e6
Indeed, we found that patients with DM had a shorter LE
than the entire population. When DM was diagnosed earlier
in life, the difference in LE between DM patients and the2000 to 2009.
4 2005 2006 2007 2008 2009 p for trend
8% 3.38% 3.15% 3.12% 3.04% 2.92% <0.01
6% 3.11% 2.88% 2.90% 2.79% 2.71%
5% 3.64% 3.42% 3.35% 3.28% 3.12%
1% 1.57% 1.44% 1.40% 1.27% 1.23% 0.06
6% 1.54% 1.35% 1.43% 1.07% 1.18%
3% 1.80% 1.69% 1.52% 1.42% 1.31%
2% 1.39% 1.26% 1.29% 1.17% 1.29% 0.4
f Taiwanese in 2005.
ealth Organization (WHO) in 2000.
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Mortality in patients with diabetes in Taiwan 649entire population was greater. Importantly, men, but not
women, with DM diagnosed at birth showed a greater
reduction in LE than did men with diabetes diagnosed at the
age of 40. These data suggest that either preventing or
delaying the onset of DM is another way to improve the
health outcome in DM patients, especially in men. In
a previous survey conducted in 1999e2004 in Taiwan, the
incidence of DM increased only in men aged 20e40 years,
a finding that differed from the incidence in women and
older men.14 Overall, the findings suggest that, in order to
further reduce the health burden of DM in Taiwan, young
men should be the first target group for the prevention of
DM. In the U.S., a National Health Interview Survey
(1984e2000) estimated that Americans with DM lost 11.6
(men) and 14.3 (women) life years when DM was diagnosed
at the age of 40.15 Although the estimated loss of life-years
due to DM differs between Americans and Taiwanese, it is
difficult to make an accurate comparison because of
differences in the statistical analysis methods used.
However, this potential difference remains interesting and
should be explored in a future study to see whether
different ethnic groups and health care systems have
different effects on LE in patients with DM.
Patients in the Cancer Prevention Study-II were enrolled
in 1982 and followed until 2008.3 Those with DM had
a higher risk of death from circulatory, respiratory, diges-
tive, and genitourinary disorders in addition to external
causes/accidental deaths. The major four causes of death
in DM patients in the cohort were cardiovascular system,
cancer, DM, and respiratory disorders. In Taiwan, malig-
nancy has replaced DM to become the leading cause of
death in men with DM since 2006. The top three causes of
death were the same in Taiwan as in the Cancer Prevention
Study-II cohort: namely DM, malignancies, and heart
diseases. Pneumonia, which is a respiratory disorder, was
the fifth most frequent cause of death in Taiwan in 2005,
2007, and 2009. Based on these findings, more effort should
be made to further reduce the mortality rate of patients
with DM, and it is especially important to improve the
control of DM and the management of malignancies, heart
diseases, and cerebrovascular diseases.
The strength of this study was its large sample size and
representativeness. As the NHI has 99% coverage in Taiwan,
the findings of the present study are highly representative.
In addition, linkage with the National Death Registry
enabled us to precisely determine the vital status of every
individual with DM included in this study. However, there is
also a limitation. We cannot exclude the possibility that
some DM patients may have sought health services paid for
by themselves and could have been misclassified as non-
diabetic. Nonetheless, they may only comprise a minority
of patients diagnosed with DM, because the coverage of the
NHI is extensive and medical care for DM is costly. Impor-
tantly, the interaction of obesity and DM on mortality
should be explored, since obesity is closely related to DM
and is another important risk factor for mortality in
Taiwan.16
In conclusion, themortality of patientswithDMdecreased
from 2000 to 2009 in Taiwan. Patients with DM had a shorter
LE than the entire population. However, this difference was
reduced over time. In 2009, the estimated reduction in LE
was 6.1 years in women and 5.3 years in men (when DM was
Table 5 Major causes of death in DM patients by sex from 2000 to 2009. Percentages of cause-specific mortality among all DM
patients who died in the indicated year are shown.
Sex Cause of death 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 p for trend
Female DM 35.45% 32.16% 29.70% 31.34% 27.82% 29.48% 27.92% 27.50% 20.82% 20.21% <0.001
Malignancies 15.73% 16.34% 17.43% 17.98% 17.43% 17.90% 18.93% 19.79% 18.24% 19.21% 0.001
Heart diseases 6.32% 7.19% 8.36% 7.68% 8.78% 8.21% 8.33% 8.90% 11.23% 10.75% 0.001
Cerebrovascular diseases 11.21% 11.36% 9.74% 9.97% 9.54% 9.80% 10.15% 9.39% 8.42% 7.52% 0.001
Male DM 26.17% 23.93% 22.82% 24.76% 20.47% 23.14% 20.89% 21.32% 15.78% 15.73% 0.001
Malignancies 21.35% 21.78% 22.37% 22.10% 23.06% 22.82% 25.01% 25.29% 24.07% 25.13% <0.001
Heart diseases 6.74% 7.61% 7.78% 7.56% 8.85% 8.01% 8.12% 8.20% 10.48% 9.76% 0.003
Cerebrovascular diseases 10.06% 9.51% 8.94% 8.49% 8.73% 9.04% 9.54% 8.75% 7.35% 7.32% 0.009
650 H.-Y. Li et al.diagnosed at the age of 40). The fourmajor causes of death in
patients with DMwere DM,malignancies, heart diseases, and
cerebrovascular diseases.
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